← FDA DRUG APPROVALS

FDA NDA · NDA050758

CELLCEPT

mycophenolate mofetil hydrochloride

Sponsor: ROCHE PALO

APPLICATION
NDA050758
TYPE
NDA
ORIGINAL APPROVAL
1998-08-12
LATEST ACTION
2026-07-29
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CELLCEPT · ReferencePrescription
MYCOPHENOLATE MOFETIL HYDROCHLORIDE 500MG/VIAL · INJECTABLE · INJECTION

Approval history

2026-07-29Labeling · Supplement 56 · standardAP
2026-07-29REMS · Supplement 54AP
2025-06-27Labeling · Supplement 52 · standardLetterAP
2024-08-13REMS · Supplement 51LetterAP
2022-08-10Labeling · Supplement 48 · standardLetterAP
2022-06-06Efficacy · Supplement 49 · standardLetterAP
2022-06-06Efficacy · Supplement 47 · standardLetterAP
2021-10-22Labeling · Supplement 43 · standardLetterAP
2021-10-22Labeling · Supplement 42 · standardLetterAP
2021-08-11REMS · Supplement 45LetterAP
2021-04-21REMS · Supplement 44LetterAP
2021-01-15REMS · Supplement 41LetterAP
2019-12-13Labeling · Supplement 37 · standardLabelAP
2019-02-27Labeling · Supplement 35 · standardLabelAP
2018-08-23Labeling · Supplement 33 · standardLabelAP
2017-12-18Labeling · Supplement 34 · standardLabelAP
2016-05-26Manufacturing (CMC) · Supplement 32 · standardAP
2015-11-13REMS · Supplement 31LetterAP
2015-07-09Labeling · Supplement 30 · standardLabelAP
2013-09-27REMS · Supplement 29LetterAP
2013-09-27Labeling · Supplement 28 · standardLabelAP
2013-02-14Manufacturing (CMC) · Supplement 25 · standardAP
2012-09-25REMS · Supplement 20LetterAP
2012-06-22Labeling · Supplement 26 · standardLabelAP
2012-06-08Labeling · Supplement 24 · standardLabelAP
2009-10-08Labeling · Supplement 22 · unknownLabelAP
2009-06-18Labeling · Supplement 19 · standardLabelAP
2009-02-27Labeling · Supplement 18 · standardLetterAP
2008-12-15Labeling · Supplement 17 · standardLabelAP
2008-05-09Labeling · Supplement 16 · standardLabelAP
2007-12-20Labeling · Supplement 13 · standardLabelAP
2007-09-21Labeling · Supplement 14 · standardLetterAP
2005-10-17Labeling · Supplement 12 · standardLetterAP
2005-04-12Labeling · Supplement 10 · standardLabelAP
2003-02-28Labeling · Supplement 5 · standardLabelAP
2002-12-17Manufacturing (CMC) · Supplement 7 · standardAP
2002-02-27Manufacturing (CMC) · Supplement 6 · standardAP
2000-07-28Efficacy · Supplement 4 · standardLabelAP
2000-07-27Labeling · Supplement 3 · standardReviewAP
2000-06-16Manufacturing (CMC) · Supplement 2 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →